NEW YORK, Jan. 15, 2014 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT), concerning whether the board has breached its fiduciary......
More...